Bolt Biotherapeutics amends bylaws to reduce stockholder quorum to one-third of shares

Bolt Biotherapeutics, Inc.

Board amended bylaws on April 15, 2025, effective immediately.
Quorum requirement lowered from majority to one-third of outstanding voting shares.
Change applies to all stockholder meetings and separate class votes unless otherwise required.
No changes to fiscal year or other governance provisions.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Bolt Biotherapeutics, Inc.: Reduced quorum requirement for stockholder meetings from a majority to one-third of outstanding shares (effective 2025-04-15).

Change: bylaw amendment
Effective: 2025-04-15

Exact text from the filing

On April 15, 2025, the board of directors of Bolt Biotherapeutics, Inc. (the “Company”) amended and restated the Company’s amended and restated bylaws (as amended and restated, the “Amended and Restated Bylaws”), effective immediately.

View on SEC.gov

59 governance changes filed in the last 30 days. Browse all governance changes →

Bolt Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-054871

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.